Multinational validation of distant metastasis velocity as a post-progression prognostic score in patients with oligometastatic cancer treated with metastasis-directed stereotactic body radiotherapy.

Saved in:
Bibliographic Details
Title: Multinational validation of distant metastasis velocity as a post-progression prognostic score in patients with oligometastatic cancer treated with metastasis-directed stereotactic body radiotherapy.
Authors: Willmann J; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: jonas.willmann@usz.ch., Baker S; Department of Radiation Oncology, University of British Columbia, British Columbia, Canada., Chen H; Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Canada., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA., Vlaskou Badra E; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland., Christ SM; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland., Mayinger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland., Ahmadsei M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland., Adilovic S; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland., Das S; Department of Radiation Oncology, University of British Columbia, British Columbia, Canada., Lechner L; Department of Radiation Oncology, University of British Columbia, British Columbia, Canada., Liu W; Department of Radiation Oncology, University of British Columbia, British Columbia, Canada., Liu M; Department of Radiation Oncology, University of British Columbia, British Columbia, Canada., Mou B; Department of Radiation Oncology, University of British Columbia, British Columbia, Canada., Berrang T; Department of Radiation Oncology, University of British Columbia, British Columbia, Canada., Schellenberg D; Department of Radiation Oncology, University of British Columbia, British Columbia, Canada., Tyldesley S; Department of Radiation Oncology, University of British Columbia, British Columbia, Canada., Erler D; Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Canada., Iyengar P; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA., Redmond K; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD, USA., Ricardi U; Department of Oncology, University of Turin, Turin, Italy., Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland., Sahgal A; Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Canada., Olson R; Department of Radiation Oncology, University of British Columbia, British Columbia, Canada., Andratschke N; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Oct 01; Vol. 228, pp. 115737. Date of Electronic Publication: 2025 Aug 23.
Publication Type: Journal Article; Validation Study; Multicenter Study
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2025.115737